Company
regado biosciences
- Business model
- B2B
Record updated 28 September 2026
About
A public company focused on use of aptamers for reversible treatments in acute care cardiovascular markets. Acquired by Tobira Therapeutics. (NASDAQ: TBRA)
Company
Record updated 28 September 2026
A public company focused on use of aptamers for reversible treatments in acute care cardiovascular markets. Acquired by Tobira Therapeutics. (NASDAQ: TBRA)
A first look at regado biosciences’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.